Log in

PTC Therapeutics Earnings Date, Estimates & History

-1.70 (-3.15 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $52.19
50-Day Range
MA: $49.65
52-Week Range
Now: $52.19
Volume709,527 shs
Average Volume760,468 shs
Market Capitalization$3.53 billion
P/E RatioN/A
Dividend YieldN/A


PTC Therapeutics (NASDAQ:PTCT) Earnings Information

PTC Therapeutics last issued its quarterly earnings results on October 29th, 2020. The biopharmaceutical company reported ($1.03) earnings per share for the quarter, beating analysts' consensus estimates of ($1.10) by $0.07. The business had revenue of $82.71 million for the quarter, compared to analyst estimates of $112.21 million. Its revenue was up 15.9% on a year-over-year basis. PTC Therapeutics has generated ($3.45) earnings per share over the last year. PTC Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 1st, 2021 based off prior year's report dates.

PTC Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PTC Therapeutics (NASDAQ:PTCT) Earnings Estimates

2020 EPS Consensus Estimate: ($6.00)
2021 EPS Consensus Estimate: ($9.10)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($1.36)($0.69)($1.03)
Q2 20202($1.06)($0.82)($0.94)
Q3 20202($2.12)($2.02)($2.07)
Q4 20202($2.11)($1.82)($1.97)
Q1 20211($2.19)($2.19)($2.19)
Q2 20211($2.24)($2.24)($2.24)
Q3 20211($2.39)($2.39)($2.39)
Q4 20211($2.28)($2.28)($2.28)

PTC Therapeutics (NASDAQ PTCT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
10/29/20209/30/2020($1.10)($1.03)($1.03)$112.21 million$82.71 millionTranscript
8/5/20206/30/2020($1.29)($2.78)($2.52)$82.04 million$75.24 millionTranscript
4/30/20203/31/2020($1.00)($1.81)($1.79)$81.90 million$68.30 millionTranscript
3/2/2020Q4 2019($0.53)($1.37)($0.93)$94.93 million$96.46 millionTranscript
10/29/2019Q3 2019($0.91)($1.06)($0.72)$72.03 million$71.40 millionTranscript
8/6/2019Q2 2019($0.46)($0.66)($0.57)$78.65 million$85.50 millionListen
5/2/20193/31/2019($0.74)($1.29)($0.53)$70.38 million$53.58 millionTranscript
2/28/2019Q4 2018($0.43)($0.46)$0.04$85.41 million$86.34 millionN/A
11/5/20189/30/2018($0.40)($1.06)($0.82)$70.56 million$53.59 millionTranscript
8/7/2018Q2 2018($0.36)($0.21)$0.03$69.83 million$68.74 millionN/A
5/9/2018Q1 2018($0.43)($0.46)($0.46)$63.46 million$56.10 millionN/A
3/6/2018Q4 2017($0.14)$0.03$0.03$78.59 million$78.00 millionTranscript
11/2/2017Q3 2017($0.66)($0.67)($0.52)$48.25 million$41.85 millionN/A
8/8/2017Q2 2017($0.89)($0.44)($0.44)$28.78 million$47.96 millionListen
5/8/2017Q1 2017($0.88)($0.85)($0.85)$27.93 million$26.50 millionListen
3/16/2017Q4 2016($0.99)($0.78)($0.78)$24.69 million$25.20 millionN/A
11/2/2016Q3 2016($1.21)($1.03)($1.03)$19.76 million$23.00 millionN/A
8/4/2016Q2 2016($1.28)($1.14)($1.14)$15.24 million$15.40 millionN/A
5/5/2016Q1 2016($1.21)($1.16)($1.10)$13.74 million$18.90 millionN/A
2/29/2016Q4 2015($1.27)($1.50)($1.50)$13.04 million$12.70 millionListen
11/9/2015Q3 2015($1.12)($1.27)($1.27)$9.88 million$9.78 millionListen
7/30/2015Q2 2015($1.20)($1.14)($1.14)$7.73 million$6.77 millionListen
5/4/2015Q1 2015($1.31)($1.15)($1.15)$2.97 million$7.50 millionN/A
2/27/2015Q4 2014($0.83)($0.84)($0.84)$7.99 million$12.70 millionListen
11/6/2014Q3 2014($0.91)($0.93)($0.93)$1.76 million$1.69 millionN/A
8/7/2014Q2 2014($0.74)($0.86)($0.86)$1.71 million$1.70 millionN/A
5/6/2014Q1 2014($0.44)($0.58)($0.58)$10.93 million$9.22 millionN/A
3/6/2014Q4 2013($0.58)($0.75)($0.75)$6.15 million$4.40 millionN/A
11/14/2013Q3 2013($0.29)($0.19)($0.19)$7.20 million$16.29 millionListen
8/13/2013Q2 2013($0.71)($5.51)($5.51)$6.33 million$6.85 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.